🇺🇸 FDA
Patent

US 10155798

Anti-obesity compounds derived from neuromedin U

granted A61KA61K38/00A61K38/22

Quick answer

US patent 10155798 (Anti-obesity compounds derived from neuromedin U) held by The Regents of the University of California expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/22, A61K47/543, A61P